SLN NASDAQ
Silence Therapeutics plc
1W: -4.8%
1M: -28.1%
3M: +0.6%
YTD: +73.0%
1Y: +108.6%
3Y: +9.7%
5Y: -51.2%
$10.64
-0.07 (-0.65%)
Weekly Expected Move ±5.2%
$10
$10
$11
$11
$12
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$46M
+7.9% ▲
Capital Expenditures
$55K
+73.9% ▲
5Y CAGR: -36.0%
Free Cash Flow
-$62M
+8.1% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$82M
-255.5% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$62M | -$50M | -$50M | -$36M | -$89M |
| Depreciation & Amort. | $576K | $596K | $498K | $593K | $312K |
| Stock-Based Comp. | $12M | $13M | $13M | $13M | $8M |
| Change in Working Capital | $52M | -$19M | -$12M | -$33M | $8M |
| Other Non-Cash Items | $468K | -$1M | $9M | -$13M | $26M |
| Operating Cash Flow | $9M | -$57M | -$39M | -$68M | -$46M |
| — Investing Activities — | |||||
| Capital Expenditures | -$2M | -$173K | -$45K | -$211K | -$55K |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | -$20M | -$21M | -$139M | -$166M |
| Investment Sales | $13M | $0 | $36M | $0 | $0 |
| Other Investing | -$18K | -$372K | $958K | $117M | $131M |
| Investing Cash Flow | $12M | -$20M | $16M | -$22M | -$36M |
| — Financing Activities — | |||||
| Net Debt Issuance | -$285K | $0 | -$174K | $0 | $0 |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | -$0 | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $41M | $53M | $25M | $142M | $11K |
| Net Change in Cash | $62M | -$33M | -$785K | $53M | -$82M |
| Cash End of Period | $99M | $66M | $54M | $121M | $8M |
| Free Cash Flow | $7M | -$58M | -$39M | -$68M | -$62M |